cabazitaxel (jevtana) for progressive metastatic prostate cancer after taxotere
Published 12 years ago • 3.1K plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
6:09
docetaxel (taxotere) for progressive, metastatic prostate cancer
-
4:31
taxotere vs. jevtana - chemotherapy for prostate cancer | ask a prostate expert, mark scholz, md
-
7:09
cabazitaxel use in metastatic prostate cancer
-
4:17
prostate cancer: abiraterone for progressive metastatic disease
-
4:10
prostate cancer: chemotherapy for metastatic disease
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
5:34
provenge for progressive metastatic prostate cancer
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer
-
3:00
ogx-011, a potentially new drug for hormone refractory prostate cancer
-
2:23
new controversy over provenge for progressive metastatic prostate cancer
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
2:32
dr. sweeney on the optimal use of cabazitaxel
-
0:34
jevtana’s toxicity profile makes it a good option in metastatic prostate cancer
-
5:11
provenge for progressive metastatic prostate cancer
-
9:41
jevtana® (cabazitaxel) mechanism of action
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
2:44
prostate cancer: how to manage metastatic
-
3:47
cabazitaxel safe and effective in mcrpc